Department of Biomedical Sciences and Clinical Oncology, University of Bari, 'Aldo Moro', 70121 Bari, Italy.
National Cancer Research Center, Istituto Tumori 'Giovanni Paolo II', 70121 Bari, Italy.
Int J Mol Sci. 2019 Dec 20;21(1):52. doi: 10.3390/ijms21010052.
Cutaneous melanoma shows a high metastatic potential based on its ability to overcome the immune system's control. The mechanisms activated for these functions vary extremely and are also represented by the production of a number of extracellular vesicles including exosomes. Other vesicles showing a potential role in the melanoma progression include oncosomes and melanosomes and the majority of them mediate tumor processes including angiogenesis, immune regulation, and modifications of the micro-environment. Moreover, a number of epigenetic modifications have been described in melanoma and abundant production of altered microRNAs (mi-RNAs), non-coding RNAs, histones, and abnormal DNA methylation have been associated with different phases of melanoma progression. In addition, exosomes, miRNAs, and other molecular factors have been used as potential biomarkers reflecting disease evolution while others have been suggested to be potential druggable molecules for therapeutic application.
皮肤黑色素瘤具有很高的转移潜能,这是基于其能够克服免疫系统的控制。这些功能所激活的机制变化非常大,也表现为大量细胞外囊泡的产生,包括外泌体。其他在黑色素瘤进展中显示出潜在作用的囊泡包括肿瘤小体和黑色素体,其中大多数介导肿瘤过程,包括血管生成、免疫调节和微环境的改变。此外,在黑色素瘤中已经描述了许多表观遗传修饰,并且大量改变的 microRNAs (miRNAs)、非编码 RNA、组蛋白和异常的 DNA 甲基化与黑色素瘤进展的不同阶段相关。此外,外泌体、miRNAs 和其他分子因子已被用作反映疾病演变的潜在生物标志物,而其他因子则被认为是治疗应用的潜在可用药分子。